InsiderTrades.com logo
📉 Warning: Market Crash Predicted - Secure Your Savings
From Behind the Markets   |   Ad
The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.
Take these 4 steps to protect your retirement here >>>

CERO Insider Trading

Insider Ownership Percentage: 18.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $325,000.00

CERo Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at CERo Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CERo Therapeutics Share Price & Price History

Current Price: $0.19
Price Change: ▼ Price Decrease of -0.02 (-9.65%)
As of 11/14/2024 01:00 AM ET

This chart shows the closing price history over time for CERO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Election warning coming true…
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - watch it before it's too late.
Click here to watch it now.

CERo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/10/2024Bioventures Opportunities G YkMajor ShareholderSell3,250,000$0.10$325,000.0022,620,783View SEC Filing Icon  
See Full Table
Top "Sleeping Giant" Crypto In The Market Now
From Crypto 101 Media   |   Ad
Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.
Click here to discover our #1 crypto pick before it's too late

SEC Filings (Institutional Ownership Changes) for CERo Therapeutics (NASDAQ:CERO)

29.64% of CERo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CERo Therapeutics logo
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Read More on CERo Therapeutics

Today's Range

Now: $0.19
Low: $0.18
High: $0.21

50 Day Range

MA: $0.10
Low: $0.07
High: $0.27

52 Week Range

Now: $0.19
Low: $0.06
High: $12.80

Volume

11,922,732 shs

Average Volume

15,181,584 shs

Market Capitalization

$28.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CERo Therapeutics?

CERo Therapeutics' top insider investors include:
  1. Bioventures Opportunities G Yk (Major Shareholder)
Learn More about top insider investors at CERo Therapeutics.
Watch this before it gets removed
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.